PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Jun-2021 Jasper Therapeutics to Host Webcast to Review Updated 90-day Data from Phase 1 Clinical Trial of JSP191 That is Being Presented at 2021 ASCO Virtual Annual Meeting Businesswire
01-Jun-2021 ValenzaBio Appoints Biotech Veteran Gregory Keenan, M.D., as Chief Medical Officer Businesswire
01-Jun-2021 “New Science” is Driving More Growth than Predicted Against a Changing Economic Environment, According to Accenture Report Businesswire
01-Jun-2021 Severe Heart Failure Treatment: FineHeart Successfully Raises €15 million Series B funding With Industrial and Independent Investors Businesswire
01-Jun-2021 Janssen Reports New Data for BCMA CAR-T, Cilta-Cel, Showing Deep and Durable Responses in Patients with Relapsed or Refractory Multiple Myeloma Businesswire
01-Jun-2021  Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients Businesswire
01-Jun-2021 Istari Oncology to Present Data from its PVSRIPO Immunotherapy Platform at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting Businesswire
01-Jun-2021 National Plaintiffs’ Firm DiCello Levitt Hires Civil Justice Champion Diandra “Fu” Debrosse Zimmermann to Join Firm’s Elite Bench of Trial Attorneys Businesswire
01-Jun-2021 PharmaCord Appoints Whitney Mardis to Vice President, Patient Services Newswire
01-Jun-2021 nVent Launches High Power Retention Technology with New nVent RAYCHEM HTV Heating Cable Businesswire
01-Jun-2021 Lengo Therapeutics Appoints Diana Hausman as Chief Medical Officer Businesswire
01-Jun-2021 Sesen Bio Strengthens Senior Leadership Team Businesswire
01-Jun-2021 Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis Amgen and Kyowa Kirin
01-Jun-2021 Sanofi provides update on venglustat clinical program Sanofi
01-Jun-2021 Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine Businesswire
01-Jun-2021 NexTech AR Solutions Announces Appointment of New CFO Businesswire
01-Jun-2021 Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures Businesswire
01-Jun-2021 Mycovia Pharmaceuticals Submits New Drug Application to the U.S. FDA for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis Businesswire
01-Jun-2021 NHS treats first patient with the ‘world’s most expensive drug’ NHS England
01-Jun-2021 Personnel changes at Merck Group level to further push science & technology based strategic growth trajectory Merck Group